Elevated Psychiatry adds Creyos cognitive testing to ADHD evaluations in Hawaiʻi

Elevated Psychiatry in Honolulu is adding Creyos, a cognitive assessment platform, to adult ADHD evaluations at no extra cost. The practice says the tool gives clinicians objective data on attention, memory, executive function and verbal reasoning while complementing, not replacing, a full psychiatric evaluation.

Why it matters: - Elevated Psychiatry is adding an objective cognitive layer to ADHD evaluations for adults in Honolulu and across Hawaiʻi. - The change may help clinicians better understand attention, memory, executive function and verbal reasoning alongside interview-based assessment. - The practice is offering Creyos at no additional cost as part of its comprehensive ADHD evaluations.

What happened: - Elevated Psychiatry, formerly Elevating Minds Psychiatry, introduced Creyos cognitive testing for ADHD evaluations. - The Honolulu practice says the platform is intended to support comprehensive ADHD care for adults throughout Hawaiʻi. - Daniel Mattox, PMHNP-BC, owner, founder and nurse practitioner at Elevated Psychiatry, said Creyos adds information that can be considered with a patient's history, symptoms and clinical interview.

The details: - Creyos is a brief cognitive assessment that patients complete at home on a laptop or tablet in about 30 minutes. - The platform measures four cognitive domains commonly relevant to ADHD: attention, memory, executive function and verbal reasoning. - The tasks are presented as short, game-like activities, which the practice says many patients may find more engaging than traditional testing. - Elevated Psychiatry says the cognitive tasks used in Creyos have been used in published cognitive research for decades. - The practice says remote completion can make the assessment easier for busy professionals, college students and adults balancing work and family responsibilities. - The platform can serve as a baseline before treatment begins, allowing later comparison after medication management, behavioral strategies or ADHD coaching. - Standalone Creyos testing is available for patients who want to complete the assessment independently. - Standalone pricing is $100 for current patients and $200 for new or non-patients. - The assessment is cash-pay, generally not billed to insurance and typically not reimbursable. - Patients can ask about the assessment during appointments or message the practice through the patient portal. - Elevated Psychiatry says Creyos is included in comprehensive ADHD evaluations at no extra cost. - The practice also says standalone plan and pricing details are available for more information. - Social links and contact details provided in the release include Daniel Mattox, PMHNP-BC, Elevating Minds Psychiatry and phone number +1 (808) 563-4128.

Between the lines: - The launch reflects a broader push to make ADHD assessment more evidence-informed without adding much burden to patients. - Elevated Psychiatry is positioning Creyos as a supplement to clinical judgment, not a substitute for it. - Mattox said the practice wants baseline cognitive data to help track change over time and to match patients with the right level of evaluation. - The practice explicitly says Creyos is not a diagnostic test for ADHD and not a replacement for a comprehensive psychiatric evaluation. - Elevated Psychiatry also says Creyos is not a neuropsychological evaluation and does not replace specialized testing for learning disability, forensic, dementia or comprehensive neuropsychological assessments when those are clinically appropriate.

What's next: - Elevated Psychiatry plans to continue expanding evidence-based ADHD care in Hawaiʻi through psychiatry, medication management, telepsychiatry, psychotherapy and Creyos testing. - Patients interested in the new assessment can discuss it at their next appointment or through the patient portal. - The practice says it will refer patients to higher-level testing when more specialized cognitive assessment is needed.

The bottom line: - Elevated Psychiatry is using Creyos to add quick, at-home cognitive data to ADHD evaluations while keeping the diagnostic decision in the hands of clinicians.